找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Cosmetics; Controlled Efficacy P. Elsner,Howard I. Maibach (Professor),Hans F. Me Book 1999 Springer-Verlag Berlin Heidelberg 1999 ageing.

[復(fù)制鏈接]
樓主: 要求
41#
發(fā)表于 2025-3-28 16:10:00 | 只看該作者
Ruth McNerlan,Yaxin Bi,Guoze Zhao,Bing Han We will provide here information about the PAL, especially about those regulations related to efficacy claims for cosmetics (We use the term of efficacy simply here; however, it can also denote clinical effectiveness, usefulness and even product claims).
42#
發(fā)表于 2025-3-28 21:45:22 | 只看該作者
43#
發(fā)表于 2025-3-28 23:18:31 | 只看該作者
44#
發(fā)表于 2025-3-29 04:43:45 | 只看該作者
45#
發(fā)表于 2025-3-29 10:43:07 | 只看該作者
to Article 7b, special claims of efficacy could be legally attributed to cosmetic products but under the obligation to make evidence of the claimed effects; also an entirely new "controller" was introduced - the independent "safety assessor", This indeed means not only progress in reliable and hones
46#
發(fā)表于 2025-3-29 15:05:48 | 只看該作者
Michael Crowhurst,Michael Emslieons for its use and disposal as well as any other indication or information provided by the manufacturer or his authorized agent or by any other person responsible for placing the product on the Community market” [1].
47#
發(fā)表于 2025-3-29 16:29:39 | 只看該作者
Zhiwei Luo,Rong Xie,Wangyi Huang,Yiwei Shann Europe, for example, the European Cosmetic Directive requires that products have documentation to support the claims made [1]. In the United States the requirement is essentially the same except that some products that are considered cosmetic in some regulatory jurisdictions are over-the-counter drug products in the United States.
48#
發(fā)表于 2025-3-29 20:16:32 | 只看該作者
Siegfried Bodenmann,Anne-Lise Reyributed to wider use. As available products have proliferated in the marketplace, claims regarding performance and efficacy of self-tanning lotions have been refined and broadened for promotion to an enlarging consumer base.
49#
發(fā)表于 2025-3-30 00:11:46 | 只看該作者
50#
發(fā)表于 2025-3-30 07:38:35 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-12 15:14
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
奈曼旗| 临清市| 闻喜县| 拉萨市| 桐梓县| 福州市| 仁布县| 宝坻区| 珠海市| 南乐县| 循化| 朝阳区| 和平区| 泾川县| 德保县| 陆川县| 曲阜市| 北安市| 武威市| 宜昌市| 甘德县| 晋江市| 陇川县| 陈巴尔虎旗| 墨玉县| 东至县| 米脂县| 泰州市| 镇巴县| 朝阳县| 阜康市| 玉屏| 庐江县| 海原县| 峡江县| 梓潼县| 永年县| 永康市| 冷水江市| 宜兰市| 涟水县|